Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Shah

Showing results (31-40 of 180) with videos related to

Pageof 18
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2001
Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected womenRichard D Semba, Nina Shah, Robert S Klein, et al.
Hospital Practice (1995)|April 29, 2014
Insulin requirements in non-critically ill hospitalized patients with diabetes and steroid-induced hyperglycemiaElias K Spanakis, Nina Shah, Keya Malhotra, et al.
Journal of Psychoactive Drugs|February 17, 2006
Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: the need for early interventionSusan G Sherman, Crystal M Fuller, Nina Shah, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 27, 2026
Effectiveness and safety of trastuzumab-anns compared to reference trastuzumab among patients with HER2-positive breast cancer: A non-inferiority studyPatrick Shin, Fang Niu, Dara D Nguyen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 22, 2023
Outcomes of weight-based vs. fixed dose of Pembrolizumab among patients with non-small cell lung cancerLena Chaitesipaseut, Nina Shah, Thach-Giao Truong, et al.
European Journal of Haematology|August 25, 2019
Estimation of minimally important differences and responder definitions for EORTC QLQ-MY20 scores in multiple myeloma patientsKate Sully, Andrew Trigg, Nicola Bonner, et al.
Frontiers in Oncology|December 23, 2021
Early Dynamics and Depth of Response in Multiple Myeloma Patients Treated With BCMA CAR-T CellsSandy W Wong, Nina Shah, Guy Ledergor, et al.
Frontiers in Medicine|December 24, 2015
Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical TrialsRohtesh S Mehta, Katayoun Rezvani, Amanda Olson, et al.
Circulation Research|May 3, 2021
Mechanisms of Cardiovascular Toxicities Associated With ImmunotherapiesAlan H Baik, Olalekan O Oluwole, Douglas B Johnson, et al.
Blood Advances|July 25, 2020
Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myelomaJoaquin Martinez-Lopez, Sandy W Wong, Nina Shah, et al.
Pageof 18

Showing results (31-40 of 180) with videos related to

Sort By:
Pageof 18
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2001
Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected womenRichard D Semba, Nina Shah, Robert S Klein, et al.
Hospital Practice (1995)|April 29, 2014
Insulin requirements in non-critically ill hospitalized patients with diabetes and steroid-induced hyperglycemiaElias K Spanakis, Nina Shah, Keya Malhotra, et al.
Journal of Psychoactive Drugs|February 17, 2006
Correlates of initiation of injection drug use among young drug users in Baltimore, Maryland: the need for early interventionSusan G Sherman, Crystal M Fuller, Nina Shah, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|March 27, 2026
Effectiveness and safety of trastuzumab-anns compared to reference trastuzumab among patients with HER2-positive breast cancer: A non-inferiority studyPatrick Shin, Fang Niu, Dara D Nguyen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 22, 2023
Outcomes of weight-based vs. fixed dose of Pembrolizumab among patients with non-small cell lung cancerLena Chaitesipaseut, Nina Shah, Thach-Giao Truong, et al.
European Journal of Haematology|August 25, 2019
Estimation of minimally important differences and responder definitions for EORTC QLQ-MY20 scores in multiple myeloma patientsKate Sully, Andrew Trigg, Nicola Bonner, et al.
Frontiers in Oncology|December 23, 2021
Early Dynamics and Depth of Response in Multiple Myeloma Patients Treated With BCMA CAR-T CellsSandy W Wong, Nina Shah, Guy Ledergor, et al.
Frontiers in Medicine|December 24, 2015
Novel Techniques for Ex Vivo Expansion of Cord Blood: Clinical TrialsRohtesh S Mehta, Katayoun Rezvani, Amanda Olson, et al.
Circulation Research|May 3, 2021
Mechanisms of Cardiovascular Toxicities Associated With ImmunotherapiesAlan H Baik, Olalekan O Oluwole, Douglas B Johnson, et al.
Blood Advances|July 25, 2020
Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myelomaJoaquin Martinez-Lopez, Sandy W Wong, Nina Shah, et al.
Pageof 18